NIST AI RMF vs. EU AI Act in Healthcare & Banking: A Practical Compliance Checklist
The short answer
The NIST AI RMF tells you how to manage AI risk; the EU AI Act tells you what is legally required for each risk tier. Healthcare and banking teams get the most from using NIST as the operating model and the EU AI Act as the checklist that model must satisfy — one control library, two sets of evidence.
Two frameworks, one governance program
Compliance and engineering leaders in regulated industries keep asking the same question: do we need a NIST program and a separate EU AI Act program? In practice, no. Running two parallel efforts doubles the paperwork and splits ownership. The better approach is one set of controls, mapped to both.
This matters most in healthcare and financial services, where AI already sits on top of existing obligations — HIPAA, GLBA, model risk guidance such as SR 11-7, and FINRA supervision rules. Neither framework replaces those; both help you show they are being applied to AI.
Side by side: NIST AI RMF and the EU AI Act
| Dimension | NIST AI RMF | EU AI Act |
|---|---|---|
| Legal status | Voluntary U.S. framework | Binding EU regulation |
| Structure | Four functions: Govern, Map, Measure, Manage | Risk tiers: prohibited, high-risk, limited-risk, minimal-risk |
| Focus | How to manage AI risk across the lifecycle | What obligations apply to each type of AI system |
| Who it applies to | Any organization that adopts it | Providers and deployers whose AI reaches the EU market |
| Evidence expected | Internal policies, risk assessments, measurement results | Technical documentation, logging, human oversight, conformity records |
| Best used as | The operating model for your control library | The legal checklist your control library must cover |
How the four NIST functions map to EU AI Act duties
- Govern — policies, accountability, and training. Covers the Act's expectations for a risk management system and organizational responsibility.
- Map — context, intended use, and risk identification. This is where each system gets its EU risk tier.
- Measure — testing for accuracy, robustness, and bias. Produces the evidence behind the Act's data quality and accuracy requirements.
- Manage — monitoring, incident response, and human oversight. Matches the Act's logging, oversight, and post-market monitoring duties.
Where healthcare and banking feel it most
In banking, credit scoring and creditworthiness decisions about individuals are named high-risk uses under the EU AI Act, and they already fall under model risk management expectations in the U.S. In healthcare, AI that supports clinical decisions or forms part of a regulated medical device draws the closest scrutiny, while HIPAA governs the patient data behind it. Insurers face both, since life and health insurance pricing is also listed as high-risk.
Lower-risk uses — internal search, drafting assistance, document summarization — usually carry lighter obligations, but they still need an inventory entry, access controls, and a named owner.
A 10-point AI compliance checklist
- Keep a live inventory of every AI system, including vendor tools and embedded features.
- Assign each system a risk tier, and map high-risk uses (credit decisions, insurance pricing, clinical support) explicitly.
- Name an accountable business owner and a technical owner for every production system.
- Document intended use, data sources, and known limitations before go-live.
- Confirm data access follows HIPAA or GLBA rules, with permissions enforced at retrieval time.
- Test for accuracy, bias, and robustness against a documented baseline before release.
- Define where human review is required and record who approved each decision it covers.
- Log inputs, outputs, and model versions so any decision can be reconstructed for an auditor.
- Monitor quality, drift, and incidents continuously, with a clear escalation path.
- Review vendor AI contracts for data use, audit rights, and change notification.
Teams that can check all ten have the foundation for both frameworks. Where gaps remain, our AI Governance Maturity Model shows which stage you are at and what to build next. This article is general guidance, not legal advice.
Frequently asked questions
What is the difference between the NIST AI RMF and the EU AI Act?
The NIST AI Risk Management Framework is a voluntary U.S. framework organized around four functions: Govern, Map, Measure, and Manage. The EU AI Act is a binding regulation that sorts AI systems into risk tiers and sets legal obligations for each tier. NIST describes how to manage risk; the EU AI Act defines what is required.
Is the NIST AI RMF mandatory for healthcare or banking?
No. The NIST AI RMF is voluntary. However, healthcare and banking organizations already operate under binding rules such as HIPAA, GLBA, and model risk guidance like SR 11-7, and the NIST functions are a practical way to show those rules are being applied to AI systems.
Does the EU AI Act apply to U.S. healthcare and financial companies?
It can. The EU AI Act applies to organizations that place AI systems on the EU market or whose AI outputs are used in the EU, regardless of where the company is based. Organizations with EU patients, customers, or operations should confirm their exposure with legal counsel.
Which AI uses in healthcare and banking are likely high-risk under the EU AI Act?
The Act lists creditworthiness assessment and credit scoring of individuals, and pricing or risk assessment for life and health insurance, as high-risk uses. AI that is a safety component of a regulated medical device can also be high-risk. Classification depends on the specific use, so each system should be assessed individually.
Can one governance program satisfy both frameworks?
Largely, yes. A single control library built on the NIST functions — inventory, risk tiering, documentation, testing, monitoring, and human oversight — produces most of the evidence the EU AI Act expects. Gaps usually appear in formal conformity documentation and regulator-facing records.